Tesamorelin is a GHRH analog approved for HIV-associated lipodystrophy and studied for visceral fat. It is researched most often for Visceral fat reduction, Metabolic health and Cognitive studies. FDA-approved for a specific indication; studied off-label. This guide walks through what Tesamorelin is, how it's studied, what it's commonly combined with, and — just as important — where the science stops. It's educational information only, not medical advice.
What is Tesamorelin?
Tesamorelin is a stabilized GHRH analog that is FDA-approved to reduce excess visceral (abdominal) fat in people with HIV-associated lipodystrophy. It has also been studied for cognitive and metabolic outcomes.
Also known as: TH9507.
How does Tesamorelin work?
Tesamorelin is a stabilized GHRH analog that boosts the body's growth-hormone axis. Unlike most research peptides, it is FDA-approved for a specific indication — reducing excess visceral (abdominal) fat in people with HIV-associated lipodystrophy — and has also been studied for cognitive and metabolic outcomes.
What is Tesamorelin researched for?
In the research and community discussion, Tesamorelin comes up most often in connection with Visceral fat reduction, Metabolic health and Cognitive studies. Remember that "researched for" is not the same as "proven to treat" — these are the directions the science has explored, not established outcomes.
- Visceral fat reduction
- Metabolic health
- Cognitive studies
What does the research actually show?
FDA-approved for a specific indication; studied off-label. The honest framing matters here: promising mechanisms and early results are genuinely interesting, but they are not the same as proven, approved therapy. Anyone presenting Tesamorelin as a guaranteed treatment is getting ahead of the evidence.
What is Tesamorelin typically stacked with?
In the literature and community discussion, Tesamorelin is most often combined with Ipamorelin, based on complementary mechanisms. Selpho never provides dosing or protocols — combinations should only be considered with a licensed professional, since interactions and individual context matter.
Safety and considerations
Prescription medication for its approved use. Affects growth hormone axis. Because the responsible framing is educational rather than prescriptive, Selpho provides no dosing, protocols, or purchase links, and always points back to a licensed professional for any decision. If you are dealing with a real health concern, that professional — not a peptide — is where planning should start.
Where to learn more about Tesamorelin
To go deeper, see the Tesamorelin library page for a quick reference; published research on PubMed; Selpho's free AI Peptide Advisor to see where Tesamorelin might fit your goals.
Frequently asked questions
It is FDA-approved to reduce excess visceral abdominal fat in people with HIV-associated lipodystrophy. Other uses are off-label or investigational.
Its approved evidence is specific to HIV-associated visceral fat. Broader use is not established and it affects the growth-hormone axis.
Yes, for its approved use. It should only be used under medical supervision.
Not sure if Tesamorelin fits your goals?
Describe your situation and Selpho's free AI advisor will suggest research-backed peptides — no signup needed.
Try the Peptide AdvisorThis guide is for educational purposes only and is not medical advice, a diagnosis, or a recommendation to use any compound. It contains no dosing or purchase information. Always consult a licensed healthcare professional before considering any peptide.